-
1
-
-
37049065602
-
Reductions with Raney alloy in acid solution
-
Es T.V., Staskun B. Reductions with Raney alloy in acid solution. J. Chem. Soc. 4:1965;5775-5777.
-
(1965)
J. Chem. Soc.
, vol.4
, pp. 5775-5777
-
-
Es, T.V.1
Staskun, B.2
-
2
-
-
85034956876
-
Role of protic and dipolar aprotic solvents in heterocyclic syntheses via 1,3-dipolar cycloaddition reactions
-
Kadaba P.K. Role of protic and dipolar aprotic solvents in heterocyclic syntheses via 1,3-dipolar cycloaddition reactions. Synthesis. 1:1973;71-84.
-
(1973)
Synthesis
, vol.1
, pp. 71-84
-
-
Kadaba, P.K.1
-
3
-
-
0016607915
-
Triazolines VIII. Action of diazoalkanes on heterocyclic substituted schiff bases
-
Kadaba P.K. Triazolines VIII. Action of diazoalkanes on heterocyclic substituted schiff bases. J. Heterocyclic Chem. 12:1975;143-146.
-
(1975)
J. Heterocyclic Chem.
, vol.12
, pp. 143-146
-
-
Kadaba, P.K.1
-
4
-
-
1842802177
-
Triazolines; XI. Oxidation of 1H-4,5-dihydro 1,2,3-triazoles using phase-transfer catalysis. A useful synthetic route to 5-heterocyclic substituted 1,2,3-triazoles
-
Kadaba, P.K., 1978. Triazolines; XI. Oxidation of 1H-4,5-dihydro 1,2,3-triazoles using phase-transfer catalysis. A useful synthetic route to 5-heterocyclic substituted 1,2,3-triazoles. Synthesis 9, 694-695.
-
(1978)
Synthesis
, vol.9
, pp. 694-695
-
-
Kadaba, P.K.1
-
5
-
-
0023866307
-
Triazolines 14. 1,2,3-Triazolines and triazoles, a new class of anticonvulsants. Drug design and structure-activity relationships
-
Kadaba P.K. Triazolines 14. 1,2,3-Triazolines and triazoles, a new class of anticonvulsants. Drug design and structure-activity relationships. J. Med. Chem. 31:1988;196-203.
-
(1988)
J. Med. Chem.
, vol.31
, pp. 196-203
-
-
Kadaba, P.K.1
-
6
-
-
15844425962
-
Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents
-
Li J.J., Norton M.B., Reinhard E.J., Anderson G.D., Gregory S.A., Isakson P.C., Koboldt C.M., Masferrer J.L., Perkins W.E., Seibert K., Zhang Y., Zweifel B.S., Reitz D.B. Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents. J. Med. Chem. 39:1996;1846-1856.
-
(1996)
J. Med. Chem.
, vol.39
, pp. 1846-1856
-
-
Li, J.J.1
Norton, M.B.2
Reinhard, E.J.3
Anderson, G.D.4
Gregory, S.A.5
Isakson, P.C.6
Koboldt, C.M.7
Masferrer, J.L.8
Perkins, W.E.9
Seibert, K.10
Zhang, Y.11
Zweifel, B.S.12
Reitz, D.B.13
-
7
-
-
0036297993
-
Synthesis of stable isotopically labeled versions of iamotrigine and its methylated metabolite
-
Manning C.O., Wadsworth A.H., Fellows I. Synthesis of stable isotopically labeled versions of iamotrigine and its methylated metabolite. J Labelled Compd. Radiopharm. 45:2002;611-618.
-
(2002)
J Labelled Compd. Radiopharm.
, vol.45
, pp. 611-618
-
-
Manning, C.O.1
Wadsworth, A.H.2
Fellows, I.3
-
12
-
-
0026592095
-
Synthesis of carbone-14 and tritium labelled analogs of the novel antischizophernic agent clozapine
-
Sunay U.B., Talbot K.C., Galullo V. Synthesis of carbone-14 and tritium labelled analogs of the novel antischizophernic agent clozapine. J. Labelled Compd. Radiopharm. 31:1992;1041-1047.
-
(1992)
J. Labelled Compd. Radiopharm.
, vol.31
, pp. 1041-1047
-
-
Sunay, U.B.1
Talbot, K.C.2
Galullo, V.3
-
13
-
-
0034624748
-
4-[5-Methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: A potent and selective inhibitor of COX-2
-
Talley J.J., Brown D.L., Carter J.S., Graneto M.J., Koboldt C.M., Masferrer J.L., Perkins W.E., Rogers R.S., Shaffer A.F., Zhang Y.Y., Zweifel B.S., Seibert K. 4-[5-Methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib. a potent and selective inhibitor of COX-2 J. Med. Chem. 43:2000;775-777.
-
(2000)
J. Med. Chem.
, vol.43
, pp. 775-777
-
-
Talley, J.J.1
Brown, D.L.2
Carter, J.S.3
Graneto, M.J.4
Koboldt, C.M.5
Masferrer, J.L.6
Perkins, W.E.7
Rogers, R.S.8
Shaffer, A.F.9
Zhang, Y.Y.10
Zweifel, B.S.11
Seibert, K.12
|